Pampa award for poet KS Nissar Ahmed

Mangaluru, May 5: The Dakshina Kannada district administration has denotified two containment zones, Sampya in Puttur and Thumbe in Bantwal. They were declared containment zones after one coronavirus positive case was reported from each area.

All the primary and secondary contacts of the patients have completed home quarantine period, said DC Sindhu B Rupesh.

The district administration hitherto had already denotified three other such containment zones based on a report of DHO,  after no new case was reported in the area in the last 28 days.

At present, the district has six containment zones-- Shakthinagara, Boloor, First Neuro Hospital in Mangaluru city, Uppinangady in Puttur, Kasaba and Narikombu in Bantwal taluk.

Bengaluru, Jun 25: A total of 442 new cases of COVID-19 were reported in Karnataka on Thursday taking the total count of cases in the state to 10,560.

According to the State Health Department, there are 3,716 active cases and 6,670 patients have been discharged after treatment. Six more deaths have been reported in the last 24 hours, taking the death toll to 170.

India's COVID-19 count reached 4,73,105 on Thursday with the highest single-day spike of 16,922 cases in the last 24 hours.

Mangaluru, May 23: Criticising the Karnataka government's fresh protocol for management of Covid-19 as expensive, a prominent physician in the city has demanded its withdrawal.

According to Dr B Srinivas Kakkilaya, the protocol released by the Health and Family Welfare Department on May 15 enlists unnecessary and unconfirmed tests and treatments. 

The protocol has classified Covid-19 cases into three categories and has provided for hospitalisation of all three categories of patients, from asymptomatic to the most severely ill.

In a letter to the government, Dr Kakkilaya said: "The protocol suggests several investigations to be done right on the day of admission, including blood counts, liver and renal function tests, chest X Ray, ECG, CT scan of the chest, and other special investigations, all of which, if done, will cost Rs 25,000 per patient."

"In the coming days when lakhs of patients are likely to be infected with SARS CoV2, is it necessary and feasible to hospitalise and test all these patients at Rs 25,000 per person," he questioned.

The treatment options suggested in the protocol are also surprising, he pointed out. "The protocol recommends choloroquine, azithromycin, oseltamivir, zinc and vitamin C for all patients, from asymptomatic to the severely ill, and also anti coagulant injections for many patients. All these would cost at least Rs 5,000 per patient. For severe cases of Covid-19, many unproven and experimental treatments have been suggested, which are very expensive and highly questionable," Dr Kakkilaya notes.

Therefore, this protocol, he asserted was not evidence based and likely to do more harm than good. He said these unnecessarily expensive tests and allowing private companies to conduct trials on Covid-19 patients is likely to be misused by vested interests and must be immediately withdrawn, and instead, a protocol that is evidence-based, simple and avoiding unnecessary expenses, must be developed.